Deferiprone
Active substance: deferiprone
TABLET, COATED · DEFERIPRONE 500 mg/1
United StatesActive
Marketing holder: Hikma Pharmaceuticals USA Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- DEFERIPRONE · 500 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 3 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-461c-7a03-92e1-360f3cdfb893,01a1208d-be71-7f0b-b83a-8f1aa5b6c5c8,01a1208e-ceee-7db3-8b99-ed34b1525fb1,01a12091-6921-7f1e-8573-ad21760b46b7,01a12092-7849-7559-a3a1-a15c7c389ed7;count=10 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0054-0576
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0054-0576 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0054-0576 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0054-0576 · Verified 2026-10-09 · open in source